Metraipolis › archive › dc_cfdbdb1f593b

Assessing Quality of Life and Patient-Reported Outcomes in Diabetic Macular Edema Treated With Anti-vascular Endothelial Growth Factor (Anti-VEGF) Agents: A… — Europe PMC PMID:41322822

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41322822
DOI: 10.7759/cureus.95469
License (as archived): solo-consultazione
Archived: 2026-11-09T01:24:43.418Z
SHA-256 of the archived text: aee69d49ad394df8413747b3553b2897a98bae28198f21444db9456a319cfd1f
Stable URL of this page: https://metraipolis.com/documento/dc_cfdbdb1f593b

How to cite

Assessing Quality of Life and Patient-Reported Outcomes in Diabetic Macular Edema Treated With Anti-vascular Endothelial Growth Factor (Anti-VEGF) Agents: A… — Europe PMC PMID:41322822 — Europe PMC (en), https://europepmc.org/article/MED/41322822 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_cfdbdb1f593b (Metraipolis archive dc_cfdbdb1f593b, sha256 aee69d49ad394df8413747b3553b2897a98bae28198f21444db9456a319cfd1f)

BibTeX

@misc{dccfdbdb1f593b,
  title = {Assessing Quality of Life and Patient-Reported Outcomes in Diabetic Macular Edema Treated With Anti-vascular Endothelial Growth Factor (Anti-VEGF) Agents: A… — Europe PMC PMID:41322822},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41322822},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_cfdbdb1f593b; sha256 aee69d49ad394df8413747b3553b2897a98bae28198f21444db9456a319cfd1f},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41322822. Agents can read the archived copy with the MCP tool read_document.